United States · Exchanges & live quotes · Nasdaq
Two Ways to Play Biotech: FBT’s Return Edge vs. IBB’s Cost Advantage
Detailed summary
Key PointsFirst Trust NYSE Arca Biotechnology Index Fund maintains a more concentrated portfolio of 30 holdings compared to the 243 positions found in iShares Biotechnology ETF.
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.nasdaq.com)
